• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向选择性组蛋白去乙酰化酶抑制剂设计:人类I类组蛋白去乙酰化酶的同源建模、对接研究及分子动力学模拟

Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.

作者信息

Wang Di-Fei, Helquist Paul, Wiech Norbert L, Wiest Olaf

机构信息

Walther Cancer Research Center and Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556-5670, USA.

出版信息

J Med Chem. 2005 Nov 3;48(22):6936-47. doi: 10.1021/jm0505011.

DOI:10.1021/jm0505011
PMID:16250652
Abstract

Histone deacetylases (HDACs) play an important role in gene transcription. Inhibitors of HDACs induce cell differentiation and suppress cell proliferation in tumor cells. Although many HDAC inhibitors have been designed and synthesized, selective inhibition for class I HDAC isoforms is a goal that has yet to be achieved. To understand the difference between class I HDAC isoforms that could be exploited for the design of isoform-specific HDAC inhibitors, we have built three-dimensional models of four class I histone deacetylases, HDAC1, HDAC2, HDAC3, and HDAC8. Comparison of the homology model of HDAC8 with the recently published X-ray structure shows excellent agreement and validates the approach. A series of HDAC inhibitors were docked to the homology models to understand the similarities and differences between the binding modes. Molecular dynamic simulations of these HDAC-inhibitor complexes indicate that the interaction between the protein surface and inhibitor is playing an important role; also some active site residues show some flexibility, which is usually not included in routine docking protocols. The implications of these results for the design of isoform-selective HDAC inhibitors are discussed.

摘要

组蛋白去乙酰化酶(HDACs)在基因转录中发挥着重要作用。HDACs抑制剂可诱导肿瘤细胞分化并抑制其增殖。尽管已经设计并合成了许多HDAC抑制剂,但对I类HDAC亚型的选择性抑制仍是一个尚未实现的目标。为了了解I类HDAC亚型之间的差异,以便用于设计亚型特异性HDAC抑制剂,我们构建了四种I类组蛋白去乙酰化酶HDAC1、HDAC2、HDAC3和HDAC8的三维模型。HDAC8的同源模型与最近发表的X射线结构的比较显示出极佳的一致性,并验证了该方法。将一系列HDAC抑制剂对接至同源模型,以了解结合模式之间的异同。这些HDAC-抑制剂复合物的分子动力学模拟表明,蛋白质表面与抑制剂之间的相互作用起着重要作用;此外,一些活性位点残基表现出一定的灵活性,这在常规对接方案中通常未被考虑。本文讨论了这些结果对亚型选择性HDAC抑制剂设计的意义。

相似文献

1
Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.迈向选择性组蛋白去乙酰化酶抑制剂设计:人类I类组蛋白去乙酰化酶的同源建模、对接研究及分子动力学模拟
J Med Chem. 2005 Nov 3;48(22):6936-47. doi: 10.1021/jm0505011.
2
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.II类选择性组蛋白去乙酰化酶抑制剂选择性的结构起源
J Med Chem. 2008 May 22;51(10):2898-906. doi: 10.1021/jm7015254. Epub 2008 Apr 16.
3
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.将羟肟酸对接进入 HDAC1 和 HDAC8:对活性趋势和选择性的合理化解释。
J Chem Inf Model. 2009 Dec;49(12):2774-85. doi: 10.1021/ci900288e.
4
On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors.类组蛋白去乙酰化酶蛋白14 Å长内部腔的功能:对组蛋白去乙酰化酶抑制剂设计的启示
J Med Chem. 2004 Jun 17;47(13):3409-17. doi: 10.1021/jm0498497.
5
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).利用选择性组蛋白去乙酰化酶1/组蛋白去乙酰化酶2抑制剂(SHI-1:2)对组蛋白去乙酰化酶(HDAC)内腔进行探索。
Bioorg Med Chem Lett. 2008 Feb 1;18(3):973-8. doi: 10.1016/j.bmcl.2007.12.031. Epub 2008 Jan 7.
6
Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.“无连接子”异羟肟酸作为选择性HDAC8抑制剂的设计与评价
Bioorg Med Chem Lett. 2007 May 15;17(10):2874-8. doi: 10.1016/j.bmcl.2007.02.064. Epub 2007 Feb 25.
7
Identification of novel isoform-selective inhibitors within class I histone deacetylases.I类组蛋白去乙酰化酶中新的亚型选择性抑制剂的鉴定
J Pharmacol Exp Ther. 2003 Nov;307(2):720-8. doi: 10.1124/jpet.103.055541. Epub 2003 Sep 15.
8
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.人类HDAC8的结构快照为I类组蛋白去乙酰化酶提供了深入见解。
Structure. 2004 Jul;12(7):1325-34. doi: 10.1016/j.str.2004.04.012.
9
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.小分子组蛋白去乙酰化酶抑制剂的类别和亚型选择性的测定
Biochem J. 2008 Jan 15;409(2):581-9. doi: 10.1042/BJ20070779.
10
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.1类和2类组蛋白去乙酰化酶的底物和抑制剂特异性
J Biotechnol. 2006 Jun 25;124(1):258-70. doi: 10.1016/j.jbiotec.2006.01.030. Epub 2006 Mar 29.

引用本文的文献

1
Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents.喹唑啉类组蛋白去乙酰化酶抑制剂作为抗癌药物的研究进展
Mini Rev Med Chem. 2024;24(22):1983-2007. doi: 10.2174/0113895575303614240527093106.
2
Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs.芹菜素及其与伏立诺他的联合使用通过调节表观遗传和凋亡调节因子以及相关的微小RNA,诱导三阴性乳腺癌细胞发生凋亡介导的细胞死亡。
Sci Rep. 2024 Apr 25;14(1):9540. doi: 10.1038/s41598-024-60395-x.
3
A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors.
组蛋白去乙酰化酶亚型的分子对接研究综述:设计选择性抑制剂的新工具
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1639. doi: 10.3390/ph16121639.
4
Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.基于药效团的 ZINC 数据库虚拟筛选、分子建模及设计新型衍生物作为潜在的 HDAC6 抑制剂。
Mol Divers. 2023 Oct;27(5):2053-2071. doi: 10.1007/s11030-022-10540-3. Epub 2022 Oct 10.
5
Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment.基于二甲双胍和组蛋白去乙酰化酶抑制剂的抗炎纳米平台用于抑制上皮-间充质转化和转移性肿瘤治疗。
J Nanobiotechnology. 2022 Aug 31;20(1):394. doi: 10.1186/s12951-022-01592-6.
6
In-silico discovery of dual active molecule to restore synaptic wiring against autism spectrum disorder via HDAC2 and H3R inhibition.通过抑制 HDAC2 和 H3R 来恢复突触连接,从而对抗自闭症谱系障碍的双活性分子的计算机发现。
PLoS One. 2022 Jul 25;17(7):e0268139. doi: 10.1371/journal.pone.0268139. eCollection 2022.
7
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain.用于脑内组蛋白去乙酰化酶1和2成像的首个高效且特异的基于苯甲酰胺的放射性示踪剂[F]BA3的研发及生物学评价
Pharmaceuticals (Basel). 2022 Mar 8;15(3):324. doi: 10.3390/ph15030324.
8
Improving protein-ligand docking and screening accuracies by incorporating a scoring function correction term.通过纳入打分函数校正项来提高蛋白-配体对接和筛选的准确性。
Brief Bioinform. 2022 May 13;23(3). doi: 10.1093/bib/bbac051.
9
Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation.基于配体的药效团模型和分子动力学模拟鉴定新型 HDAC3 有效抑制剂。
Sci Rep. 2022 Feb 2;12(1):1712. doi: 10.1038/s41598-022-05698-7.
10
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts.组蛋白去乙酰化酶1、2和3的抑制增强了尼曼-皮克C1型成纤维细胞中胆固醇积累的清除。
ACS Pharmacol Transl Sci. 2021 May 27;4(3):1136-1148. doi: 10.1021/acsptsci.1c00033. eCollection 2021 Jun 11.